Biotek-snakken — December 2020
-
Mesoblast - FDA giver Fast Track Designation til Remestemcel-L i ARDS - stiger +15% i pre market - http://investorsmedia.mesoblast.com/static-files/046bf826-c5bf-4606-a0b2-0420f8c7a933
-
Mens Orphazyme ligger på årets laveste:( Medwatch: https://medwatch.dk/Medicinal___Biotek/article12600722.ece?utm_source=Feed&utm_medium=latest
-
...og samme fra investor news - https://ml-eu.globenewswire.com/Resource/Download/0fb226ec-3bf5-4779-a34e-30cbaa248402
-
Endnu en dag, endnu en nyhed fra Zymeworks
Exelixis udnytter option på ICON-2
https://ir.zymeworks.com/News-Releases/news-details/2020/Exelixis-In-Licenses-Iconic-Therapeutics-Tissue-Factor-Targeting-Antibody-Drug-Conjugate-Ahead-of-Planned-Investigational-New-Drug-Application/default.aspx -
Scandion Onkology præsentation: https://www.biostock.se/2020/12/biostock-studio-scandion-oncology-outlines-vision-to-fight-cancer-drug-resistance/
-
En investors spændende tanker om $TRIL og konkurrenter i CD47. https://drive.google.com/file/d/1izk0BFPtslVRCsui3VzElU2lTNqrA16p/view
-
God nat:)
-
Det bliver spændende med Sutros STRO-002 data i dag. Webcast kl. 23.00
-
Hansa Biopharma hos ØU. Nu med link som virker: https://vimeo.com/483997561?mc_eid=513463285b&mc_cid=87d7874648
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind